May 20-22, 2025 | Hamburg, Germany
Pelago Bioscience is excited to announce our participation in SLAS Europe 2025 in Hamburg, Germany, from May 20-22. As a leading provider of innovative solutions for drug discovery, we will present the latest insights from our CETSA® technology and how it enables more efficient screening and target engagement insights.
Our Team at the Conference:
- Erwin Brenndörfer, Senior Project Advisor, Pelago Bioscience
Join Us for These Key Sessions:
- Talk: CETSA-based evaluation of non-degraded PROTAC targets
Date: May 22, 2025
Time: 16:00–16:30
In this session, Erwin Brenndörfer will share how CETSA can evaluate PROTAC targets, providing valuable insights into their function and potential for drug discovery. This talk will highlight the advantages of CETSA in screening applications, especially for evaluating targets in their native state.
- Poster Presentation: Identification of novel p53 modulating compounds through rapid high-throughput CETSA screening
Date: May 22, 2025
Time: 14:00–15:00
During this poster session, Erwin Brenndörfer will present how CETSA technology is applied to the high-throughput identification of novel p53 modulating compounds, a significant advancement in cancer research.
Pelago Bioscience is proud to contribute to the ongoing evolution of drug discovery technologies, and we look forward to connecting with the SLAS community in Hamburg.